Healthcare costs and resource utilization in patients with severe aplastic anemia in the US-Reference-Cited by-同舟云学术

Healthcare costs and resource utilization in patients with severe aplastic anemia in the US

Published:2019-08-04 Issue:10 Volume:22 Page:1055-1062
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Cai Beilei¹,Said Qayyim¹,Li Xin²,Li Frank (Yunfeng)¹,Arcona Steve¹

Affiliation:

1. US Oncology Health Economics and Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA;

2. KMK Consulting Inc, Morristown, NJ, USA

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2019.1643354

Reference18 articles.

1. National Heart, Lung, and Blood Institute (NHLBI). What is aplastic anemia. 2018 [cited 2018 Aug 31]. Available from: https://www.nhlbi.nih.gov/node/80148.

2. Current concepts in the pathophysiology and treatment of aplastic anemia

3. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia

4. Antithymocyte Globulin and Cyclosporine for Severe Aplastic Anemia

5. Photochemical Coatings for the Prevention of Bacterial Colonization

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hospitalization of patients with nutritional anemia in the United States in 2020;Frontiers in Public Health;2024-05-13

2. Real-World Costs and Cost-Effectiveness Analysis of Rabbit-Antithymocyte Globulin Versus Oxymetholone in Acquired Aplastic Anemia in Thailand;Value in Health Regional Issues;2023-09

3. A New Immunosuppressive Therapy for Very Severe Aplastic Anemia in Children with Autoantibodies;Current Medical Science;2022-03-08

4. Healthcare resource use and direct costs in severe aplastic anemia (SAA) patients before and after treatment with eltrombopag;Journal of Medical Economics;2019-11-20